Outset Medical (OM) Short-term Investments (2019 - 2026)

Outset Medical (OM) has 8 years of Short-term Investments data on file, last reported at $126.1 million in Q1 2026.

• On a quarterly basis, Short-term Investments rose 11.56% year-over-year to $126.1 million in Q1 2026; TTM through Mar 2026 was $126.1 million, a 11.56% increase from a year earlier, with the FY2025 full-year figure at $133.9 million, up 286.32% from the prior year.
• Short-term Investments for Q1 2026 stood at $126.1 million, down from $133.9 million in the prior quarter.
• Over the last five years, Short-term Investments for OM reached as high as $214.3 million in Q4 2022 and fell as low as $34.7 million in Q4 2024.
• Historically, Short-term Investments has averaged $154.9 million across 5 years, with a median of $157.0 million in 2024.
• Across the five-year window, Short-term Investments soared 630.73% in 2022 and slumped 74.28% in 2024, its largest moves.
• Year by year, Short-term Investments stood at $214.3 million in 2022, then sank by 37.08% to $134.8 million in 2023, then slumped by 74.28% to $34.7 million in 2024, then jumped by 286.32% to $133.9 million in 2025, then retreated by 5.82% to $126.1 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $126.1 million in Q1 2026, $133.9 million in Q4 2025, and $142.2 million in Q3 2025.